公开(公告)号：US20230125634A1

公开(公告)日：2023-04-27

申请号：US17914727

申请日：2020-12-29

申请人： BEPLUS LAB. INC

发明人： Uk LEE ,  Hoon Jae CHUNG ,  Chan YOON

IPC分类号： G16H10/60 ,  G16H10/20 ,  G16H50/30 ,  G16H50/70

摘要： A method for predicting a developmental disease is disclosed. According to one aspect of the present invention, disclosed is a method for predicting a developmental disease including preparing a list of multiple symptoms and a list of multiple diseases, respectively, matching the symptoms with the diseases related to the symptoms, differentially setting correlation scores for the symptoms matched with the diseases according to prevalence rates of the diseases for the symptoms, for each disease, providing a user with the list of multiple symptoms and receiving, from the user, at least one selection of the symptoms that correspond to the user, and deriving predicted disease information in an order of a highest sum score by summing up scores related to the symptoms selected by the user for each disease and calculating the sum score.

公开(公告)号：US20230120168A1

公开(公告)日：2023-04-20

申请号：US17755516

申请日：2021-05-06

申请人： LOKKS307 INC. ,  C&R RESEARCH INC.

发明人： Byeongyeob OH ,  Byungln Yoon ,  Jeonil Kang

IPC分类号： G16H10/20 ,  G16H10/60 ,  G16H20/10

摘要： A method and system for blockchain-based medicine-taking management for a clinical trial subject are disclosed. The method for managing clinical trial medicine-taking comprises the steps of: providing a notification for managing medication for a clinical trial medicine through a medication management app; receiving a medication log of the clinical trial subject by scanning a QR code on the clinical trial medicine through the medication management application; storing the received medication log in a blockchain as medication management information of the clinical trial subject; and verifying the validity of the medication log by using the blockchain.

公开(公告)号：US11631499B2

公开(公告)日：2023-04-18

申请号：US15931402

申请日：2020-05-13

申请人： William E. Hayward

发明人： William E. Hayward

IPC分类号： G16H50/30 ,  G16H10/20 ,  G06V10/40 ,  G06F3/04842 ,  G06Q10/00 ,  G06Q50/16 ,  G16H10/60

摘要： Embodiment of the invention provide a method for determining a health index of a property area. The method comprises acquiring property data associated with a property area from a data source, and extracting a first property attribute data from the property data acquired. The first property attribute data extracted is used to determine presence or movement of a first pollutant data within the property area. The method further comprises determining a first potential impact data the first pollutant data may have on individual health based in part on the first property attribute data extracted, and computing a property score representing a health index of the property area based in part on the first potential impact data determined.

公开(公告)号：US20230116325A1

公开(公告)日：2023-04-13

申请号：US18045365

申请日：2022-10-10

申请人： OUR UNITED CORPORATION

发明人： Hao YAN ,  Zhaoqiang YANG ,  Jinsheng LI

IPC分类号： G16H80/00 ,  G16H10/60 ,  G16H10/20 ,  G16H40/20 ,  G16H20/00

摘要： Provided is a method for interaction of multi-party medical information, a computer device and a storage medium. The method includes: displaying medical statistical data of a target user in a pre-established multi-party consultation group for the target user, wherein the multi-party consultation group includes members of a plurality of medical disciplines associated with the target user and a virtual object; acquiring medical opinions for the target user fed back by the members in the multi-party consultation group; and determining, based on the medical opinions, a medical consultation conclusion for the target user.

公开(公告)号：US20230110443A1

公开(公告)日：2023-04-13

申请号：US18080927

申请日：2022-12-14

申请人： BH Labs, LLC

发明人： Kate Moloney-Egnatios

IPC分类号： A61B5/145 ,  G16H10/20 ,  G16H10/40 ,  G16H50/30 ,  G16H50/20

摘要： A set of information including manually entered health-related data for an individual or user, automatically collected health-related data for the individual or user, and test results for the individual or user may be received. In response to receiving the set of information, the manually entered health-related data for the individual or user, the automatically collected health-related data for the individual or user, and the test results for the individual or user may be integrated into a comprehensive health profile for the individual or user. Upon a request made on behalf of the individual or user, at least part of the comprehensive health profile may be provided to the individual or user.

公开(公告)号：US11626195B2

公开(公告)日：2023-04-11

申请号：US17447708

申请日：2021-09-15

申请人： Enlitic, Inc.

发明人： Kevin Lyman ,  Anthony Upton ,  Lionel Lints ,  Ben Covington

IPC分类号： G16H10/60 ,  G16H30/40 ,  G16H15/00 ,  G06K9/62 ,  G06T5/00 ,  G06T5/50 ,  G06T7/00 ,  G06T11/00 ,  G06N5/04 ,  G16H30/20 ,  G06N20/00 ,  G06F9/54 ,  G06T7/187 ,  G06T7/11 ,  G06F3/0482 ,  G06T3/40 ,  A61B5/00 ,  G16H50/20 ,  G06F21/62 ,  G06Q20/14 ,  G16H40/20 ,  G06F3/0484 ,  G06Q10/0631 ,  G16H10/20 ,  G06N5/045 ,  G06T7/10 ,  G06T11/20 ,  G06F16/245 ,  G06T7/44 ,  G06N20/20 ,  H04L67/12 ,  G06V10/22 ,  H04L67/01 ,  G06V10/82 ,  G16H50/70 ,  G06T7/70 ,  G16H50/30 ,  A61B5/055 ,  A61B6/03 ,  A61B8/00 ,  A61B6/00 ,  G06Q50/22 ,  G06F40/295 ,  G06V30/194

摘要： A method comprises displaying, via an interactive interface, a medical scan and a plurality of prompts of each prompt decision tree of a plurality of prompt decision trees in succession, beginning with automatically determined starting prompts of each prompt decision tree, in accordance with corresponding nodes of each prompt decision tree until a leaf node of each prompt decision tree is ultimately selected. Labeling data indicating the ultimately selected leaf node of each prompt decision tree is determined for the medical scan.

公开(公告)号：US20230094344A1

公开(公告)日：2023-03-30

申请号：US18062574

申请日：2022-12-06

申请人： CareCognitics, LLC

发明人： Saurabh Tara ,  Jawahar Jain ,  Vishal Agarwal ,  Lakshya Jain

IPC分类号： G16H50/30 ,  G16H10/20

摘要： A method may include collecting sensor data related to a physical or mental health of a patient. The method may include determining a series of mental evidence nodes. The method may include determining a series of mental states of the patient. Each mental state is associated with a single mental evidence node. The method may include determining an expected value for each mental evidence node based on a mental baseline of the patient. The method may include determining, after each day, a value for each corresponding mental evidence node, wherein the value for each mental evidence node includes a value from each associated mental state. The method may include determining, after each day, a deviation of the patient from the expected value. The method may include generating a mental predictive model of the mental health of the patient based on the deviation of the patient from the expected value.

公开(公告)号：US20230086712A1

公开(公告)日：2023-03-23

申请号：US17478927

申请日：2021-09-19

申请人： Dov Biran

发明人： Dov Biran

IPC分类号： G16H40/20 ,  G16H20/10 ,  G16H10/20

摘要： A two sided digital platform for medical patients and medical providers is described in this document. On the provider side, users are able to create digital healthcare assets and programs which prescribe a set of instructions to patients. These instructions may vary from a detailed long-term medical care-plan to a quick survey of questions to be filled. From the patient side, users may browse medical programs which are made open by providers, as well as be assigned personalized programs by their caregivers. Feedback is given to the system by both providers and patients, which feeds a recommendation mechanism that suggests patients relevant programs that may help them achieve healthcare and lifestyle goals. Users are able to view their programs in a compartmentalized view, whether it is providers editing their programs under both public and private settings or patients reviewing all of the programs they are enrolled in and assigned divided based on the programs' inherent instructions. Patients' adherence to programs is constantly reviewed, and intelligent notifications and motivations are presented to patients to ensure constant improvement and optimal progress.

公开(公告)号：US20230082681A1

公开(公告)日：2023-03-16

申请号：US17801241

申请日：2020-04-09

申请人： CLINOMICS INC.

发明人： Yun Sung CHO ,  Jong Hwa BHAK ,  Byung Chul KIM

IPC分类号： G16H20/60 ,  G16H10/20 ,  G16H50/30

摘要： The present invention provides a healthcare solution provision method. More specifically, the present invention relates to a composite information-based healthcare solution provision method and system in which the nutritional status of an individual is checked, and genetic information and various relevant composite information are used when prescribing, selling, promoting and suggesting a nutritional supplement to the individual, and thus personalized nutrients, nutritional supplements and food which are optimized for each individual are proposed. According to the present invention, an individual checks a genetic and environmental type thereof, and thus assumes a personal bio-constitution type which is a comprehensive body constitution type, and receives a recommendation for the most optimized nutritional supplement or food, and scientific information enabling increasing the selectivity of the individual is provided, and as a result, the effect of using the personal nutritional supplement is increased, and the advantage is achieved of avoiding the use of unnecessary nutritional supplements or reducing the level of side-effects that may happen.

公开(公告)号：US20230077323A1

公开(公告)日：2023-03-16

申请号：US17797062

申请日：2021-02-26

申请人： BRIGHT CLINICAL RESEARCH LIMITED

发明人： Tailiang XIE

IPC分类号： G06F3/04847 ,  G16H10/20

摘要： The present invention constructs a “radar” system for dynamically monitoring and guiding ongoing clinical trials. In one embodiment, the system partitions the data space into 3 primary regions comprising “favorable”, “hopeful” and “undesirable” to reflect the trial status. In one embodiment, the undesirable region comprises a futility region, and the favorable region comprises a successful region. In one embodiment, the boundaries defining these regions are subject to adjustment as the clinical trial proceeds. In one embodiment, the accumulative treatment effect, data trends, stopping boundaries, trajectory and other information are graphically displayed on the “radar” screen. In one embodiment, the system takes learning from the observed and accumulated data and performs simulations to intelligently guide the trials. In one embodiment, the system is used in re-analysis or diagnosis of clinical trials already completed and provides guidance for clinical trial design or amendment.